{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:48:42Z","timestamp":1791593322159,"version":"4.3.4"},"reference-count":20,"publisher":"Georg Thieme Verlag KG","issue":"10","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Neuropsiquiatr"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction associated with increased maternal and fetal risks during pregnancy and the puerperal period.<\/jats:p>\n                  <jats:p>To describe the longitudinal course of MG, maternal and neonatal outcomes, and the occurrence of transient neonatal myasthenia gravis (TNMG) from the pregestational period until 12 months postpartum in pregnancies complicated by MG.<\/jats:p>\n                  <jats:p>A retrospective, longitudinal case-series study of pregnancies in women with MG who were followed at a single tertiary center for neuromuscular disorders. Disease severity was assessed using the MG Foundation of America Clinical Classification (MGFA)and MG-Activities of Daily Living (MG-ADL) scale. Treatments, delivery mode, postpartum exacerbations, ventilatory support and TNMG in newborns were collected using a standardized proforma. Longitudinal MG-ADL scores were analyzed using generalized estimating equations.<\/jats:p>\n                  <jats:p>Twenty-four pregnant women with MG were included. Patients had juvenile-onset (n\u2009=\u200912, 50%) or early-onset (n\u2009=\u200912, 50%) MG, which was mostly generalized (n\u2009=\u200920, 83%). Anti-AChR antibodies were positive in 71% (n\u2009=\u200917) and anti-MuSK antibodies in 4% (n\u2009=\u20091). Pyridostigmine was the main therapy; 8% of patients (n\u2009=\u20092) experienced exacerbations during pregnancy. Cesarean delivery occurred in 60% (n\u2009=\u200912), primarily for obstetric indications. The TNMG occurred in 15% of newborns (3 out of 20), and all fully recovered. The MG-ADL scores increased during the first and third trimesters, during the postpartum period, and at 12 months postpartum. Third-trimester MG-ADL scores \u2265\u20094 were associated with the occurrence of TNMG. No maternal or neonatal deaths occurred.<\/jats:p>\n                  <jats:p>Pregnancy in MG was characterized by variable disease activity, with late gestation and the postpartum period representing clinically relevant periods of vulnerability to maternal exacerbations and neonatal involvement. Increased third-trimester MG-ADL scores, particularly among antibody-positive mothers, were associated with TNMG and postpartum exacerbations, supporting close monitoring during these periods.<\/jats:p>","DOI":"10.1055\/s-0046-1829031","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:49:03Z","timestamp":1791589743000},"page":"001-007","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes during pregnancy and the postpartum period in women with myasthenia gravis and their newborns"],"prefix":"10.1055","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6071-3788","authenticated-orcid":false,"given":"Amanda Vit\u00f3ria Freire de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-8794","authenticated-orcid":false,"given":"Ana Fl\u00e1via Andrade","family":"Lemos","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-369X","authenticated-orcid":false,"given":"Mariana Ribeiro","family":"Pereira","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4325-3414","authenticated-orcid":false,"given":"Rodrigo Siqueira Soares","family":"Frezatti","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-565X","authenticated-orcid":false,"given":"Andr\u00e9 Cleriston Jos\u00e9 dos","family":"Santos","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-1644","authenticated-orcid":false,"given":"Claudia Ferreira da Rosa","family":"Sobreira","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-2749","authenticated-orcid":false,"given":"Wilson","family":"Marques Junior","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1485-3771","authenticated-orcid":false,"given":"Pedro Jos\u00e9","family":"Tomaselli","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Faculdade de Medicina de Ribeir\u00e3o Preto, Departamento de Neuroci\u00eancias e Ci\u00eancias do Comportamento, Ribeir\u00e3o Preto SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"A R Punga","year":"2022","journal-title":"Lancet Neurol"},{"issue":"05","key":"ref2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"M N Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2474-5-42","article-title":"Myasthenia gravis and pregnancy: clinical implications and neonatal outcome","volume":"5","author":"J F T\u00e9llez-Zenteno","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"issue":"08","key":"ref4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1468-1331.2009.02689.x","article-title":"No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study","volume":"16","author":"J C Wen","year":"2009","journal-title":"Eur J Neurol"},{"issue":"04","key":"ref5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.25095","article-title":"Myasthenia gravis in pregnancy: Experience of a portuguese center","volume":"54","author":"A C Braga","year":"2016","journal-title":"Muscle Nerve"},{"issue":"03","key":"ref6","first-page":"141","article-title":"Outcome of myasthenia gravis mothers and their infants","volume":"48","author":"I Cheng","year":"2007","journal-title":"Acta Paediatr Taiwan"},{"issue":"02","key":"ref7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/1753495X211041899","article-title":"Myasthenia gravis in pregnancy: Systematic review and case series","volume":"15","author":"H Banner","year":"2022","journal-title":"Obstet Med"},{"issue":"10","key":"ref8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/01.wnl.0000082725.21444.ec","article-title":"Myasthenia gravis: consequences for pregnancy, delivery, and the newborn","volume":"61","author":"J M Hoff","year":"2003","journal-title":"Neurology"},{"issue":"06","key":"ref9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.pedneo.2021.05.020","article-title":"Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis","volume":"62","author":"S Iijima","year":"2021","journal-title":"Pediatr Neonatol"},{"issue":"04","key":"ref10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nmd.2017.01.021","article-title":"Clinical follow-up of pregnancy in myasthenia gravis patients","volume":"27","author":"R D Ducci","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"05","key":"ref11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.12359","article-title":"EFNS\/ENS Guidelines for the treatment of ocular myasthenia","volume":"21","author":"E Kerty","year":"2014","journal-title":"Eur J Neurol"},{"issue":"02","key":"ref12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/s0002-9378(87)80150-3","article-title":"Host defense during pregnancy: neutrophil chemotaxis and adherence","volume":"157","author":"P J Krause","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s0301-2115(02)00051-9","article-title":"Myasthenia gravis in pregnancy: report on 69 cases","volume":"104","author":"J Djelmis","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"02","key":"ref14","first-page":"178","article-title":"Myasthenia gravis in pregnancy","volume":"80","author":"P J Mitchell","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/s0035-3787(06)75019-6","article-title":"[Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase]","volume":"162","author":"C Ramirez","year":"2006","journal-title":"Rev Neurol (Paris)"},{"issue":"09","key":"ref16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/03007995.2025.2576597","article-title":"Exacerbation and myasthenic crisis in generalized myasthenia gravis: real-world healthcare resource utilization and cost burden in the United States","volume":"41","author":"L Jackson","year":"2025","journal-title":"Curr Med Res Opin"},{"issue":"02","key":"ref17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/ijgo.70720","article-title":"Analysis of mode of delivery according to race and ethnicity in Brazil: Application of the Robson Classification","volume":"173","author":"F RCd Santos","year":"2026","journal-title":"Int J Gynaecol Obstet"},{"issue":"07","key":"ref18","first-page":"654","article-title":"[Myasthenia gravis and pregnancy. Report on 13 cases]","volume":"32","author":"O Picone","year":"2003","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"09","key":"ref19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"A Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"02","key":"ref20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurol.2008.11.020","article-title":"[Antibodies in myasthenia gravis]","volume":"165","author":"B Eymard","year":"2009","journal-title":"Rev Neurol (Paris)"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0046-1829031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:49:04Z","timestamp":1791589744000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0046-1829031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,13]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["s00461829031"],"URL":"https:\/\/doi.org\/10.1055\/s-0046-1829031","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0004-282X","1678-4227"],"issn-type":[{"value":"0004-282X","type":"print"},{"value":"1678-4227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}